Cargando…
The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
In the last half-century, Parkinson’s disease (PD) has played a historical role in demonstrating our ability to translate preclinical scientific advances in pathology and pharmacology into highly effective clinical therapies. Yet, as highly efficacious symptomatic treatments were successfully develo...
Autores principales: | Mari, Zoltan, Mestre, Tiago A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920063/ https://www.ncbi.nlm.nih.gov/pubmed/35296034 http://dx.doi.org/10.3389/fnagi.2022.810860 |
Ejemplares similares
-
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023) -
Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023) -
The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022) -
Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases
por: Santiago, Jose A., et al.
Publicado: (2023) -
(A)symmetry during gait initiation in people with Parkinson’s disease: A motor and cortical activity exploratory study
por: Faria, Murilo Henrique, et al.
Publicado: (2023)